{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:50:32Z","timestamp":1781704232944,"version":"3.54.5"},"reference-count":39,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09838"],"award-info":[{"award-number":["19K09838"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K09655"],"award-info":[{"award-number":["22K09655"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian clear cell carcinomas (OCCs) arise from endometriotic cysts that many women develop. Biomarkers for early OCC detection need to be identified. Extracellular vesicles have attracted attention as biomarker carriers. This study aims to identify cancer-specific miRNAs as novel OCC biomarkers using tissue-exudative extracellular vesicles (Te-EVs). Te-EVs were collected from four patients with OCC on one side and a normal ovary on the other side. Microarray analysis was performed to identify cancer-specific miRNAs in Te-EVs. Serum samples obtained before and after surgery from patients with OCC and atypical endometrial hyperplasia (AEH) (controls) were compared using real-time PCR to examine changes in the detected EV miRNA levels. Thirty-seven miRNAs were &gt;2-fold upregulated on the OCC side compared with the normal ovarian side. We selected 17 miRNAs and created specific primers for 12 of these miRNAs. The levels of six EV miRNAs were significantly decreased in postoperative OCC serum compared to those in preoperative OCC serum. In contrast, no significant change was observed between the pre and postoperative values in the control group. We identified OCC tissue-specific miRNAs in the EVs secreted by OCC tissues. These EV miRNAs have potential for use as biomarkers for the early diagnosis and detection of OCC.<\/jats:p>","DOI":"10.3390\/ijms232415715","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T01:42:27Z","timestamp":1670809347000},"page":"15715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma"],"prefix":"10.3390","volume":"23","author":[{"given":"Hiroshi","family":"Maruoka","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4210-701X","authenticated-orcid":false,"given":"Tomohito","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"},{"name":"Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Tsuchihashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Toji","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Nunode","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Daimon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"},{"name":"Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Nishie","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousuke","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Kogata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0648-1370","authenticated-orcid":false,"given":"Kohei","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Komura","sequence":"additional","affiliation":[{"name":"Translational Research Program, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Ohmichi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Educational Foundation of Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki 569-8686, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,11]]},"reference":[{"key":"ref_1","unstructured":"(2022, November 19). Global Cancer Observatory: Cancer Today. Available online: https:\/\/gco.iarc.fr\/today."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"142ra94","DOI":"10.1126\/scitranslmed.3003989","article-title":"Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics","volume":"4","author":"Huttenhain","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/fon.11.135","article-title":"Protein biomarkers of ovarian cancer: The forest and the trees","volume":"8","author":"Nolen","year":"2012","journal-title":"Future Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F.O., Narod, S.A., and Akbari, M.R. (2020). CA125 and Ovarian Cancer: A Comprehensive Review. Cancers, 12.","DOI":"10.3390\/cancers12123730"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer","volume":"381","author":"Pautier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/TUB-220016","article-title":"HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer","volume":"44","author":"Samborski","year":"2022","journal-title":"Tumor Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cas.13862","article-title":"Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer","volume":"110","author":"Niu","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2014.222679","article-title":"Circulating Tumor DNA as a Liquid Biopsy for Cancer","volume":"61","author":"Heitzer","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"103109","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: A broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3322\/caac.21650","article-title":"Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions","volume":"71","author":"Cheng","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Testa, A., Venturelli, E., and Brizzi, M.F. (2021). Extracellular Vesicles: New Tools for Early Diagnosis of Breast and Genitourinary Cancers. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168430"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/med.21453","article-title":"Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies","volume":"37","author":"Han","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bevacqua, E., Ammirato, S., Cione, E., Curcio, R., Dolce, V., and Tucci, P. (2022). The potential of microRNAs as non-invasive prostate cancer biomarkers: A systematic literature review based on a machine learning approach. Cancers, 14.","DOI":"10.3390\/cancers14215418"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dansero, L., Ricceri, F., De Marco, L., Fiano, V., Nesi, G., Padroni, L., Milani, L., Caini, S., Masala, G., and Agnoli, C. (2022). Investigating the role of circulating miRNAs as biomarkers in colorectal cancer: An epidemiological systematic review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092224"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nascimento, N.P.G., Gally, T.B., Borges, G.F., Campos, L.C.G., and Kaneto, C.M. (2022). Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09936-z"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-022-06728-8","article-title":"Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: A systematic review and meta-analysis","volume":"196","author":"Nguyen","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sehovic, E., Urru, S., Chiorino, G., and Doebler, P. (2022). Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09698-8"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.18632\/oncotarget.7850","article-title":"Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/1878-0261.12371","article-title":"Exosomal microRNAs as tumor markers in epithelial ovarian cancer","volume":"12","author":"Pan","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wyman, S.K., Parkin, R.K., Mitchell, P.S., Fritz, B.R., O\u2019Briant, K., Godwin, A.K., Urban, N., Drescher, C.W., Knudsen, B.S., and Tewari, M. (2009). Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005311"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yanaihara, N., Noguchi, Y., Saito, M., Takenaka, M., Takakura, S., Yamada, K., and Okamoto, A. (2016). MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162584"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Horie, K., Nanashima, N., Yokoyama, Y., Yoshioka, H., and Watanabe, J. (2022). Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study. Molecules, 27.","DOI":"10.3390\/molecules27123953"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40364-021-00272-1","article-title":"miR-21: A non-specific biomarker of all maladies","volume":"9","author":"Jenike","year":"2021","journal-title":"Biomark. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Haider, B.A., Baras, A.S., McCall, M.N., Hertel, J.A., Cornish, T.C., and Halushka, M.K. (2014). A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089565"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.3390\/ijms160816833","article-title":"The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer","volume":"16","author":"Muralidhar","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Choi, P.W., and Ng, S.W. (2017). The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061207"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphar.2016.00271","article-title":"miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition","volume":"7","author":"Sulaiman","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/onc.2012.58","article-title":"MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/embor.2008.74","article-title":"A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells","volume":"9","author":"Burk","year":"2008","journal-title":"EMBO Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"66629","DOI":"10.18632\/oncotarget.18343","article-title":"The miR-200 family in ovarian cancer","volume":"8","author":"Koutsaki","year":"2017","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1159\/000447823","article-title":"MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3","volume":"39","author":"Wei","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21691401.2018.1553783","article-title":"MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF","volume":"47","author":"Zhao","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","article-title":"MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/ol.2016.4831","article-title":"Expression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell lines","volume":"12","author":"Liu","year":"2016","journal-title":"Oncol. Lett."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:38:08Z","timestamp":1760146688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,11]]},"references-count":39,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232415715"],"URL":"https:\/\/doi.org\/10.3390\/ijms232415715","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,11]]}}}